Company intelligence / Profile preview

GEM Tox Consultants & Labs

Greenville, North Carolina, United Stateslinkedin.com ↗

Ownership: Private
Development stage: Other

Overview

The company specializes in the evaluation, discovery, and validation of cancer biomarkers using molecular biology methods. There are no reported clinical results or therapeutic products; activities are focused on laboratory testing and research support for exposure hazards and cancer diagnostics[1].

Therapeutic areas: Oncology
Modalities: Molecular biology methods
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on GEM Tox Consultants & Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GEM Tox Consultants & Labs.

Explore the full profile